Hospital Clínico San Carlos de Madrid -ko ikertzaileekin lankidetzan egindako argitalpenak (26)

2024

  1. Interobserver Reliability and Sensitivity to Change of a Composite Ocular Inflammatory Activity Index: UVEDAI©

    Ophthalmology and Therapy, Vol. 13, Núm. 6, pp. 1669-1682

  2. Recovery course of persistent posterior subretinal fluid after successful repair of rhegmatogenous retinal detachment

    European Journal of Ophthalmology, Vol. 34, Núm. 4, pp. 1217-1227

2023

  1. Correction to: Validation of UVEDAI: An Index for Evaluating the Level of Inflammatory Activity in Uveitis (Ophthalmology and Therapy, (2023), 12, 2, (1045-1055), 10.1007/s40123-023-00654-8)

    Ophthalmology and Therapy

  2. Spontaneous resolution of inflammatory epiretinal membrane: Case series and review of the literature

    European Journal of Ophthalmology, Vol. 33, Núm. 1, pp. NP10-NP14

  3. Validation of UVEDAI: An Index for Evaluating the Level of Inflammatory Activity in Uveitis

    Ophthalmology and Therapy, Vol. 12, Núm. 2, pp. 1045-1055

2022

  1. CHARACTERIZING COVID-19-RELATED RETINAL VASCULAR OCCLUSIONS: A Case Series and Review of the Literature

    Retina (Philadelphia, Pa.), Vol. 42, Núm. 3, pp. 465-475

  2. Efficacy, safety and cost-effectiveness of methotrexate, adalimumab or their combination in non-infectious non-anterior uveitis: a protocol for a multicentre, randomised, parallel three arms, active-controlled, phase III open label with blinded outcome assessment study

    BMJ open, Vol. 12, Núm. 3, pp. e051378

  3. Vogt-Koyanagi-Harada disease in Spain

    European Journal of Ophthalmology, Vol. 32, Núm. 3, pp. 1547-1554

2020

  1. Systemic Regulatory T Cells and IL-6 as Prognostic Factors for Anatomical Improvement of Uveitic Macular Edema

    Frontiers in Immunology, Vol. 11

  2. Use of intravitreal dexamethasone implants in the treatment of diabetic macular edema: Expert recommendations using a Delphi approach

    European Journal of Ophthalmology, Vol. 30, Núm. 5, pp. 1042-1052

2019

  1. Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases

    Arthritis and Rheumatology, Vol. 71, Núm. 12, pp. 2081-2089

  2. Predictive capacity of baseline hyperreflective dots on the intravitreal dexamethasone implant (Ozurdex®) outcomes in diabetic macular edema: a multicenter study

    Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 257, Núm. 11, pp. 2381-2390

  3. Predictors for functional and anatomic outcomes in macular edema secondary to non-infectious uveitis

    PLoS ONE, Vol. 14, Núm. 1

2018

  1. Behavior of hyperreflective foci in non-infectious uveitic macular edema, a 12-month follow-up prospective study

    BMC Ophthalmology

  2. Efficacy and safety of an aflibercept treat-and-extend regimen in treatment-naïve patients with macular oedema secondary to Central Retinal Vein Occlusion (CRVO): A Prospective 12-Month, Single-Arm, Multicentre Trial

    Journal of Ophthalmology, Vol. 2018

2017

  1. Development of an activity disease score in patients with uveitis (UVEDAI)

    Rheumatology International, Vol. 37, Núm. 4, pp. 647-656

  2. New insights into the genetic component of non-infectious uveitis through an Immunochip strategy

    Journal of Medical Genetics, Vol. 54, Núm. 1, pp. 38-46

2016

  1. Clinical Manifestations and Outcomes of Syphilis-associated Uveitis in Northern Spain

    Ocular Immunology and Inflammation, Vol. 24, Núm. 2, pp. 147-152

2015

  1. Specific association of IL17A genetic variants with panuveitis

    British Journal of Ophthalmology, Vol. 99, Núm. 4, pp. 566-570

  2. Study of association of CTLA4 gene variants to non-anterior uveitis

    Tissue Antigens, Vol. 86, Núm. 5, pp. 373-376